Glucocorticoid Sparing of Benralizumab in Asthma REPLY

被引：0
|
作者：
Nair, Parameswaran [1 ]
Barker, Peter [2 ]
Goldman, Mitchell [2 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] AstraZeneca, Gaithersburg, MD USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 377卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1205 / 1205
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of benralizumab in elderly subjects with severe asthma
    Valverde-Monge, Marcela
    Cardenas, Remedios
    Garcia-Moguel, Ismael
    Rosado, Ana
    Gandolfo-Cano, Mar
    Echarren, Teresa Robledo
    del Mar Moro-Moro, Maria
    del Mar Reano Martos, Maria
    Pineda-Pineda, Rafael
    Arroba, Cristina Martin-Arriscado
    Dominguez-Ortega, Javier
    JOURNAL OF ASTHMA, 2024, 61 (03) : 232 - 237
  • [42] Benralizumab treatment of severe asthma in pregnancy: A case series
    Naftel, Jennifer
    Eames, Chellan
    Kerley, Sumita
    Whitfield, Ciara
    Rayala-Montaniel, Eleanor
    Cook, Peter
    Haitchi, Hans Michael
    Kurukulaaratchy, Ramesh J.
    Dennison, Paddy
    Coleman, Matthew
    Rupani, Hitasha
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (09): : 2919 - 2921
  • [43] Oscillometry in severe eosinophilic asthma commencing mepolizumab or benralizumab
    Fernando, M.
    Jeffrey, B.
    Tierney, C.
    Seccombe, L.
    Peters, M.
    Farah, C.
    Cottee, A.
    RESPIROLOGY, 2023, 28 : 81 - 81
  • [44] One Year Treatment with Benralizumab in Patients with Severe Asthma
    Sandhu, Y.
    Harada, N.
    Sasano, H.
    Tanabe, Y.
    Harada, S.
    Watanabe, T.
    Nishimaki, T.
    Oyama, Y.
    Abe, S.
    Ueda, S.
    Takeshige, T.
    Matsuno, K.
    Makino, F.
    Ito, J.
    Atsuta, R.
    Takahashi, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [45] Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma
    Gonzalez I, Davila
    Benitez F, Moreno
    Quirce, S.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (02) : 84 - 93
  • [46] Regional Differences in Prescribing Benralizumab for Asthma Treatment in Japan
    Kobayashi, N.
    Matsumoto, H.
    Fukuda, N.
    Kaneko, A.
    Watanabe, K.
    Horita, N.
    Hara, Y.
    Kaneko, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [47] Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma
    Matera, Maria Gabriella
    Calzetta, Luigino
    Rinaldi, Barbara
    Cazzola, Mario
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (09) : 1007 - 1013
  • [48] Effects of Benralizumab on Mucus Plugs in Eosinophilic Severe Asthma
    Matsuda, T.
    Koya, T.
    Sakai, N.
    Tanaka, M.
    Muramatsu, N.
    Murai, Y.
    Naramoto, S.
    Aoki, A.
    Kimura, Y.
    Shima, K.
    Hasegawa, T.
    Ohshima, Y.
    Watanabe, S.
    Kikuchi, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [49] Comparative Effectiveness of Dupilumab, Mepolizumab, and Benralizumab in Patients With Asthma
    Kearney, C.
    Sangani, R.
    Shankar, D.
    Law, A.
    Walkey, A. J.
    O'Connor, G. T.
    Bosch, N. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [50] Clinical Simulations Facilitated Benralizumab Development in Adolescents with Asthma
    Yan, Li
    Ward, Christine K.
    Roskos, Lorin
    Wang, Bing
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S90 - S90
12345